The next step from high-flux dialysis: Application of sorbent technology

James F. Winchester,Claudio Ronco,James A. Brady,Larry D Cowgill,Jamie A. Salsberg,Eric Yousha,Mike Choquette,Robert L. Albright,J. Clemmer,V. A. Davankov,M. P. Tsyurupa,Ludmila Pavlova,Mikhail Pavlov,Gerald Cohen,Walter H. Hörl,Frank A. Gotch,Nathan W. Levin

The next step from high-flux dialysis: Application of sorbent technology

2002

James F. Winchester
Claudio Ronco
James A. Brady
Larry D Cowgill
Jamie A. Salsberg
Eric Yousha
Mike Choquette
Robert L. Albright
J. Clemmer
V. A. Davankov
M. P. Tsyurupa
Ludmila Pavlova
Mikhail Pavlov
Gerald Cohen
Walter H. Hörl
Frank A. Gotch
Nathan W. Levin

The current foci of renal replacement therapy with dialysis are middle molecular weight toxins, consisting of small proteins, polypeptides and products of glycosylation and lipoxygenation. Conventiona

Keywords:

Intensive care medicine
Renal replacement therapy
Dialysis
Hemoperfusion
Hemodialysis
Immunology
Glycosylation
Medicine
Sorbent
Chromatography
middle molecular weight
high flux

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations